Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyLowCsA: Kidney Graft Function with Low Dose Cyclosporine and Standard Dose Myfortic
NCT01817322Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Jun 2011
- Primary completion
- Aug 2013
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 4 trial of cyclosporine, mycophenolate sodium in kidney transplant rejection, sponsored by Samsung Medical Center. Started Jun 2011; status: completed.
02
Drugs
cyclosporinemycophenolate sodium
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01817322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817322.